Advanced Enzyme Technologies Share Price
296.00+0.00 (+1.06%)
-12.70% past 1 Year
News
Advanced Enzyme gains on completing additional investment of Rs 25 lakh in ANPL
Equity
ADVENZYMES
Advanced Enzyme completes additional investment of Rs 25 lakh in ANPL
Equity
ADVENZYMES
Advanced Enzyme - Quaterly Results
Equity
ADVENZYMES
Advanced Enzymes Outlines FY27 Growth Plans with Wellfa Brand Expansion and US Nutrition Sales Boost
Equity
ADVENZYMES
Advanced Enzyme Board Recommends Final Dividend of Rs 1.35 Per Equity Share
Equity
ADVENZYMES
Advanced Enzyme Reports Strong Q4 EBITDA Growth to Rs 63.30 Crores, Margin at 31.12%
Equity
ADVENZYMES
Advanced Enzyme Technologies Q4 FY25 Net Profit Rises 62% YoY to Rs 43 Cr on 20% Revenue Growth
Equity
ADVENZYMES
Advanced Enzyme reports Profit after tax of 22.29 Crores, in the March 2026 quarter
Equity
ADVENZYMES
Advanced Enzyme - Quaterly Results
Equity
ADVENZYMES
Advanced Enzyme Technologies Q3 FY26 EBITDA Declines YoY to Rs 49.35 Crores, Margin at 28.70%.
Equity
ADVENZYMES
Advanced Enzyme Technologies Reports Q3 Revenue Growth of 6.5% YoY to Rs 180 Crores.
Equity
ADVENZYMES
Advanced Enzyme Technologies Reports Q3 Net Profit Up 13% YoY to Rs 42.50 Crores.
Equity
ADVENZYMES
Advanced Enzyme reports Profit after tax of 13.25 Crores, in the December 2025 quarter
Equity
ADVENZYMES
Advanced Enzyme Technologies informs about updates
Equity
ADVENZYMES
Advanced Enzyme Technologies informs about trading window closure
Equity
ADVENZYMES
Advanced Enzyme guides for FY26 global growth, new specialty launches, capex in India/Mexico.
Equity
ADVENZYMES
Advanced Enzyme reports Profit after tax of 22.28 Crores, in the September 2025 quarter
Equity
ADVENZYMES
Advanced Enzyme Technologies Q2 FY26 reports 20% YoY revenue growth to Rs 185 crore.
Equity
ADVENZYMES
Advance Enzyme Technologies Q2 EBITDA rises to Rs 60 crore, margin expands to 32.55 percent YoY
Equity
ADVENZYMES
Advanced Enzyme Technologies posts strong YoY Q2 consolidated net profit growth to Rs 43.40 crores.
Equity
ADVENZYMES